GSK4528287
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK4528287, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants [Phase 1]